How satisfied people with plaque psoriasis are with their treatments
Official title: Assessment of Treatment Satisfaction in Psoriasis
Funded at University of California Los Angeles · NIH-11312717 · Data updated 2026-11-12
This project will try a new questionnaire called DermSat to measure treatment satisfaction among people with plaque psoriasis.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project start | September 20, 2023 |
| Project end | February 28, 2027 |
| Funding year | 2026 |
| Award (this year) | $118,717 |
| NIH project number | 5R01AR081226-04 |
| Project ID | NIH-11312717 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults with chronic plaque psoriasis, including those with stable disease or flares, who can complete questionnaires over time are ideal candidates.
✕Less likely to help
People without plaque psoriasis, those unable or unwilling to complete surveys, or those needing immediate urgent care are unlikely to benefit directly from participating.
What this research studies
You would be asked to complete the DermSat questionnaire over time during periods when your psoriasis is stable and during flares. The team at UCLA will follow a diverse group of patients in a prospective, observational cohort and compare DermSat answers with clinical information and other patient-reported measures. They will check whether DermSat scores move with changes in symptoms, capture side effects and treatment burden, and give consistent results when repeated. The goal is to make sure the questionnaire reliably reflects patients' real experiences with their psoriasis treatments.
Why it matters
Potential benefit: If successful, DermSat could help patients and clinicians choose treatments that fit patient preferences and improve medication use and outcomes.
How similar studies have gone: Other patient-reported outcome tools in dermatology have been validated successfully, but DermSat is a new instrument specifically focused on treatment satisfaction in psoriasis.
Where this research is happening
-
University of California Los Angeles
Los Angeles, United States Active
Researchers
- Principal investigator: Armstrong, April W — University of California Los Angeles
- Study coordinator: Armstrong, April W
Related research
Other NIH-funded projects on the same topics.
-
Testing antiplatelet approaches in psoriasis to improve blood vessel health
A study at NYU School of Medicine will test antiplatelet strategies to reduce heart and blood vessel risk in adults with psoriasis.
-
Topical immunoregulatory therapy for psoriasis
A new topical treatment for psoriasis is being developed to safely reduce skin symptoms and improve quality of life.
-
Understanding psoriasis genetic signals across diverse populations
A study to uncover the genetic factors behind psoriasis in African American people using advanced genomic and epigenetic methods.
-
SerpinB3 and keratinocytes: a new path to understanding psoriasis
This NIH grant explores how a keratinocyte protein called SerpinB3 may drive plaque psoriasis, with the hope of finding new treatments for people with moderate-to-severe disease.
-
Role of a skin protein in psoriasis-related diabetes
A study explores how a skin inflammation signal may contribute to developing type 2 diabetes in people with psoriasis.
-
Anchored versus circulating enzyme therapy to calm psoriasis inflammation
Compares two ways of giving engineered enzyme medicines to help people with psoriasis reduce chronic skin inflammation.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.